Crescent Sterling’s Eli Lilly LLY Stock Holding History

Crescent Sterling’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$461K	Buy	384 +14	+4%	+$14.3K	0.41%	59
2026 Q1	$340K	Sell	370 -10	-3%	-$10.1K	0.33%	64
2025 Q4	$408K	Sell	380 -25	-6%	-$23.9K	0.42%	57
2025 Q3	$309K	Sell	405 -148	-27%	-$110K	0.33%	61
2025 Q2	$431K	Hold	553	–	–	0.48%	54
2025 Q1	$457K	Hold	553	–	–	0.47%	51
2024 Q4	$427K	Sell	553 -72	-12%	-$59.6K	0.44%	53
2024 Q3	$554K	Hold	625	–	–	0.53%	50
2024 Q2	$566K	Sell	625 -124	-17%	-$99.2K	0.54%	51
2024 Q1	$583K	Sell	749 -15	-2%	-$10.7K	0.53%	47
2023 Q4	$445K	Buy	764 +6	+0.8%	+$3.5K	0.44%	51
2023 Q3	$407K	Buy	758 +184	+32%	+$94.8K	0.43%	52
2023 Q2	$269K	Buy	+574	New	+$241K	0.26%	65
2023 Q1	–	Sell	-563	Closed	-$206K	–	76
2022 Q4	$206K	Buy	+563	New	+$200K	0.22%	66

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Crescent Sterling's LLY Position: Q2 2026 in Review

Crescent Sterling increased its Eli Lilly (LLY) stake by 3.8% in Q2 2026, buying an estimated $14.3K and bringing the position to 384 shares worth $461K. The position accounts for 0.41% of the portfolio, ranked #59.

Crescent Sterling first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $583K in Q1 2024. 1,303 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Crescent Sterling held 384 shares of Eli Lilly worth $461K as of Q2 2026.
Crescent Sterling bought 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
Eli Lilly made up 0.41% of Crescent Sterling's portfolio in Q2 2026, its #59 holding.
Crescent Sterling first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
Crescent Sterling's Eli Lilly position peaked at $583K in Q1 2024.
1,303 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Crescent Sterling's 13F filing for Q2 2026, filed 7 Jul 2026.